ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion

Glioblastoma (GBM) is the most aggressive primary intracranial tumor in adults. Chemoradiotherapy resistance and recurrence after surgery are the main malignant progression factors, leading to a high mortality rate. Therefore, the exploration of novel biomarkers and molecular mechanisms of GBM is ur...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Li, Han, Na, Zhang, Xiaoxi, Zhou, Yangmei, Chen, Rui, Zhang, Mengxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160549/
https://www.ncbi.nlm.nih.gov/pubmed/32323832
http://dx.doi.org/10.3892/or.2020.7573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160549/
https://www.ncbi.nlm.nih.gov/pubmed/32323832
http://dx.doi.org/10.3892/or.2020.7573

Ejemplares similares